Global Xerostomia (Dry Mouth) Therapeutics Market Growth 2020-2025
According to this study, over the next five years the Xerostomia (Dry Mouth) Therapeutics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Xerostomia (Dry Mouth) Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Xerostomia (Dry Mouth) Therapeutics market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Xerostomia (Dry Mouth) Therapeutics, covering the supply chain analysis, impact assessment to the Xerostomia (Dry Mouth) Therapeutics market size growth rate in several scenarios, and the measures to be undertaken by Xerostomia (Dry Mouth) Therapeutics companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Salivary Stimulants
Salivary Substitutes
Dentifrices
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
OTC
Prescription
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline plc
Acacia Pharma
Church & Dwight, Inc.
Hikma Pharmaceuticals PLC
Pendopharm
Colgate-Palmolive Company
Pfizer, Inc.
Sun Pharmaceuticals Industries Ltd.
Parnell Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc.
OraCoat
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Xerostomia (Dry Mouth) Therapeutics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Xerostomia (Dry Mouth) Therapeutics market by identifying its various subsegments.
Focuses on the key global Xerostomia (Dry Mouth) Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Xerostomia (Dry Mouth) Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Xerostomia (Dry Mouth) Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption 2015-2025
2.1.2 Xerostomia (Dry Mouth) Therapeutics Consumption CAGR by Region
2.2 Xerostomia (Dry Mouth) Therapeutics Segment by Type
2.2.1 Salivary Stimulants
2.2.2 Salivary Substitutes
2.2.3 Dentifrices
2.3 Xerostomia (Dry Mouth) Therapeutics Consumption by Type
2.3.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type (2015-2020)
2.3.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Type (2015-2020)
2.4 Xerostomia (Dry Mouth) Therapeutics Segment by Application
2.4.1 OTC
2.4.2 Prescription
2.5 Xerostomia (Dry Mouth) Therapeutics Consumption by Application
2.5.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type (2015-2020)
2.5.2 Global Xerostomia (Dry Mouth) Therapeutics Value and Market Share by Type (2015-2020)
2.5.3 Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Type (2015-2020)
3 Global Xerostomia (Dry Mouth) Therapeutics by Company
3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company
3.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Company (2018-2020)
3.1.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2018-2020)
3.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company
3.2.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Company (2018-2020)
3.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company (2018-2020)
3.3 Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Company
3.4 Global Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Xerostomia (Dry Mouth) Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Xerostomia (Dry Mouth) Therapeutics by Regions
4.1 Xerostomia (Dry Mouth) Therapeutics by Regions
4.2 Americas Xerostomia (Dry Mouth) Therapeutics Consumption Growth
4.3 APAC Xerostomia (Dry Mouth) Therapeutics Consumption Growth
4.4 Europe Xerostomia (Dry Mouth) Therapeutics Consumption Growth
4.5 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption Growth
5 Americas
5.1 Americas Xerostomia (Dry Mouth) Therapeutics Consumption by Countries
5.1.1 Americas Xerostomia (Dry Mouth) Therapeutics Consumption by Countries (2015-2020)
5.1.2 Americas Xerostomia (Dry Mouth) Therapeutics Value by Countries (2015-2020)
5.2 Americas Xerostomia (Dry Mouth) Therapeutics Consumption by Type
5.3 Americas Xerostomia (Dry Mouth) Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Xerostomia (Dry Mouth) Therapeutics Consumption by Regions
6.1.1 APAC Xerostomia (Dry Mouth) Therapeutics Consumption by Regions (2015-2020)
6.1.2 APAC Xerostomia (Dry Mouth) Therapeutics Value by Regions (2015-2020)
6.2 APAC Xerostomia (Dry Mouth) Therapeutics Consumption by Type
6.3 APAC Xerostomia (Dry Mouth) Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Xerostomia (Dry Mouth) Therapeutics by Countries
7.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Consumption by Countries (2015-2020)
7.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Value by Countries (2015-2020)
7.2 Europe Xerostomia (Dry Mouth) Therapeutics Consumption by Type
7.3 Europe Xerostomia (Dry Mouth) Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics by Countries
8.1.1 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Value by Countries (2015-2020)
8.2 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption by Type
8.3 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Xerostomia (Dry Mouth) Therapeutics Distributors
10.3 Xerostomia (Dry Mouth) Therapeutics Customer
11 Global Xerostomia (Dry Mouth) Therapeutics Market Forecast
11.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast (2021-2025)
11.2 Global Xerostomia (Dry Mouth) Therapeutics Forecast by Regions
11.2.1 Global Xerostomia (Dry Mouth) Therapeutics Forecast by Regions (2021-2025)
11.2.2 Global Xerostomia (Dry Mouth) Therapeutics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Xerostomia (Dry Mouth) Therapeutics Forecast by Type
11.8 Global Xerostomia (Dry Mouth) Therapeutics Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline plc
12.1.1 Company Information
12.1.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline plc Latest Developments
12.2 Acacia Pharma
12.2.1 Company Information
12.2.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.2.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Acacia Pharma Latest Developments
12.3 Church & Dwight, Inc.
12.3.1 Company Information
12.3.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.3.3 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Church & Dwight, Inc. Latest Developments
12.4 Hikma Pharmaceuticals PLC
12.4.1 Company Information
12.4.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hikma Pharmaceuticals PLC Latest Developments
12.5 Pendopharm
12.5.1 Company Information
12.5.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Pendopharm Latest Developments
12.6 Colgate-Palmolive Company
12.6.1 Company Information
12.6.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.6.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Colgate-Palmolive Company Latest Developments
12.7 Pfizer, Inc.
12.7.1 Company Information
12.7.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.7.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Pfizer, Inc. Latest Developments
12.8 Sun Pharmaceuticals Industries Ltd.
12.8.1 Company Information
12.8.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.8.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sun Pharmaceuticals Industries Ltd. Latest Developments
12.9 Parnell Pharmaceuticals, Inc.
12.9.1 Company Information
12.9.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Parnell Pharmaceuticals, Inc. Latest Developments
12.10 Lupin Pharmaceuticals, Inc.
12.10.1 Company Information
12.10.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.10.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Lupin Pharmaceuticals, Inc. Latest Developments
12.11 OraCoat
12.11.1 Company Information
12.11.2 Xerostomia (Dry Mouth) Therapeutics Product Offered
12.11.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 OraCoat Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Xerostomia (Dry Mouth) Therapeutics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Salivary Stimulants
Table 5. Major Players of Salivary Substitutes
Table 6. Major Players of Dentifrices
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type (2015-2020)
Table 9. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2015-2020) ($ million)
Table 10. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application (2015-2020)
Table 14. Global Xerostomia (Dry Mouth) Therapeutics Value by Application (2015-2020)
Table 15. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share by Application (2015-2020)
Table 16. Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Application (2015-2020)
Table 17. Global Xerostomia (Dry Mouth) Therapeutics Sales by Company (2017-2019) (K MT)
Table 18. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2017-2019)
Table 19. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company (2017-2019)
Table 21. Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Company (2017-2019)
Table 22. Global Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Xerostomia (Dry Mouth) Therapeutics Products Offered
Table 24. Xerostomia (Dry Mouth) Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Xerostomia (Dry Mouth) Therapeutics Consumption by Regions 2015-2020 (K MT)
Table 26. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Regions 2015-2020
Table 27. Global Xerostomia (Dry Mouth) Therapeutics Value by Regions 2015-2020 ($ Millions)
Table 28. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share by Regions 2015-2020
Table 29. Americas Xerostomia (Dry Mouth) Therapeutics Consumption by Countries (2015-2020) (K MT)
Table 30. Americas Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Countries (2015-2020)
Table 31. Americas Xerostomia (Dry Mouth) Therapeutics Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Xerostomia (Dry Mouth) Therapeutics Value Market Share by Countries (2015-2020)
Table 33. Americas Xerostomia (Dry Mouth) Therapeutics Consumption by Type (2015-2020) (K MT)
Table 34. Americas Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type (2015-2020)
Table 35. Americas Xerostomia (Dry Mouth) Therapeutics Consumption by Application (2015-2020) (K MT)
Table 36. Americas Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application (2015-2020)
Table 37. APAC Xerostomia (Dry Mouth) Therapeutics Consumption by Regions (2015-2020) (K MT)
Table 38. APAC Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Regions (2015-2020)
Table 39. APAC Xerostomia (Dry Mouth) Therapeutics Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Xerostomia (Dry Mouth) Therapeutics Value Market Share by Regions (2015-2020)
Table 41. APAC Xerostomia (Dry Mouth) Therapeutics Consumption by Type (2015-2020) (K MT)
Table 42. APAC Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type (2015-2020)
Table 43. APAC Xerostomia (Dry Mouth) Therapeutics Consumption by Application (2015-2020) (K MT)
Table 44. APAC Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application (2015-2020)
Table 45. Europe Xerostomia (Dry Mouth) Therapeutics Consumption by Countries (2015-2020) (K MT)
Table 46. Europe Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Countries (2015-2020)
Table 47. Europe Xerostomia (Dry Mouth) Therapeutics Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Xerostomia (Dry Mouth) Therapeutics Value Market Share by Countries (2015-2020)
Table 49. Europe Xerostomia (Dry Mouth) Therapeutics Consumption by Type (2015-2020) (K MT)
Table 50. Europe Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type (2015-2020)
Table 51. Europe Xerostomia (Dry Mouth) Therapeutics Consumption by Application (2015-2020) (K MT)
Table 52. Europe Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption by Countries (2015-2020) (K MT)
Table 54. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption by Type (2015-2020) (K MT)
Table 58. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption by Application (2015-2020) (K MT)
Table 60. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application (2015-2020)
Table 61. Xerostomia (Dry Mouth) Therapeutics Distributors List
Table 62. Xerostomia (Dry Mouth) Therapeutics Customer List
Table 63. Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Countries (2021-2025) (K MT)
Table 64. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Forecast by Regions
Table 65. Global Xerostomia (Dry Mouth) Therapeutics Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share Forecast by Regions
Table 67. Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Type (2021-2025) (K MT)
Table 68. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Xerostomia (Dry Mouth) Therapeutics Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share Forecast by Type (2021-2025)
Table 71. Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Application (2021-2025) (K MT)
Table 72. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Xerostomia (Dry Mouth) Therapeutics Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share Forecast by Application (2021-2025)
Table 75. GlaxoSmithKline plc Product Offered
Table 76. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 77. GlaxoSmithKline plc Main Business
Table 78. GlaxoSmithKline plc Latest Developments
Table 79. GlaxoSmithKline plc Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 80. Acacia Pharma Product Offered
Table 81. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 82. Acacia Pharma Main Business
Table 83. Acacia Pharma Latest Developments
Table 84. Acacia Pharma Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 85. Church & Dwight, Inc. Product Offered
Table 86. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 87. Church & Dwight, Inc. Main Business
Table 88. Church & Dwight, Inc. Latest Developments
Table 89. Church & Dwight, Inc. Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 90. Hikma Pharmaceuticals PLC Product Offered
Table 91. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 92. Hikma Pharmaceuticals PLC Main Business
Table 93. Hikma Pharmaceuticals PLC Latest Developments
Table 94. Hikma Pharmaceuticals PLC Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 95. Pendopharm Product Offered
Table 96. Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 97. Pendopharm Main Business
Table 98. Pendopharm Latest Developments
Table 99. Pendopharm Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 100. Colgate-Palmolive Company Product Offered
Table 101. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 102. Colgate-Palmolive Company Main Business
Table 103. Colgate-Palmolive Company Latest Developments
Table 104. Colgate-Palmolive Company Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer, Inc. Product Offered
Table 106. Pfizer, Inc. Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer, Inc. Main Business
Table 108. Pfizer, Inc. Latest Developments
Table 109. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 110. Sun Pharmaceuticals Industries Ltd. Product Offered
Table 111. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. Sun Pharmaceuticals Industries Ltd. Main Business
Table 113. Sun Pharmaceuticals Industries Ltd. Latest Developments
Table 114. Sun Pharmaceuticals Industries Ltd. Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 115. Parnell Pharmaceuticals, Inc. Product Offered
Table 116. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 117. Parnell Pharmaceuticals, Inc. Main Business
Table 118. Parnell Pharmaceuticals, Inc. Latest Developments
Table 119. Parnell Pharmaceuticals, Inc. Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 120. Lupin Pharmaceuticals, Inc. Product Offered
Table 121. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 122. Lupin Pharmaceuticals, Inc. Main Business
Table 123. Lupin Pharmaceuticals, Inc. Latest Developments
Table 124. Lupin Pharmaceuticals, Inc. Basic Information, Company Total Revenue (in $ million), Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 125. OraCoat Product Offered
Table 126. OraCoat Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 127. OraCoat Main Business
Table 128. OraCoat Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. OraCoat Latest Developments
List of Figures
Figure 1. Picture of Xerostomia (Dry Mouth) Therapeutics
Figure 2. Xerostomia (Dry Mouth) Therapeutics Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Xerostomia (Dry Mouth) Therapeutics Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Xerostomia (Dry Mouth) Therapeutics Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Salivary Stimulants
Figure 7. Product Picture of Salivary Substitutes
Figure 8. Product Picture of Dentifrices
Figure 9. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type (2015-2020)
Figure 10. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share by Type (2015-2020)
Figure 11. Xerostomia (Dry Mouth) Therapeutics Consumed in OTC
Figure 12. Global Xerostomia (Dry Mouth) Therapeutics Market: OTC (2015-2020) (K MT)
Figure 13. Global Xerostomia (Dry Mouth) Therapeutics Market: OTC (2015-2020) ($ Millions)
Figure 14. Xerostomia (Dry Mouth) Therapeutics Consumed in Prescription
Figure 15. Global Xerostomia (Dry Mouth) Therapeutics Market: Prescription (2015-2020) (K MT)
Figure 16. Global Xerostomia (Dry Mouth) Therapeutics Market: Prescription (2015-2020) ($ Millions)
Figure 17. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application (2015-2020)
Figure 18. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share by Application (2015-2020)
Figure 19. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company in 2017
Figure 20. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company in 2019
Figure 21. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company in 2017
Figure 22. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company in 2019
Figure 23. Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Company in 2019
Figure 24. Global Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Regions 2015-2020
Figure 25. Global Xerostomia (Dry Mouth) Therapeutics Value Market Share by Regions 2015-2020
Figure 26. Americas Xerostomia (Dry Mouth) Therapeutics Consumption 2015-2020 (K MT)
Figure 27. Americas Xerostomia (Dry Mouth) Therapeutics Value 2015-2020 ($ Millions)
Figure 28. APAC Xerostomia (Dry Mouth) Therapeutics Consumption 2015-2020 (K MT)
Figure 29. APAC Xerostomia (Dry Mouth) Therapeutics Value 2015-2020 ($ Millions)
Figure 30. Europe Xerostomia (Dry Mouth) Therapeutics Consumption 2015-2020 (K MT)
Figure 31. Europe Xerostomia (Dry Mouth) Therapeutics Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption 2015-2020 (K MT)
Figure 33. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Value 2015-2020 ($ Millions)
Figure 34. Americas Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Countries in 2019
Figure 35. Americas Xerostomia (Dry Mouth) Therapeutics Value Market Share by Countries in 2019
Figure 36. Americas Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type in 2019
Figure 37. Americas Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application in 2019
Figure 38. United States Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 39. United States Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 41. Canada Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 43. Mexico Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Countries in 2019
Figure 45. APAC Xerostomia (Dry Mouth) Therapeutics Value Market Share by Regions in 2019
Figure 46. APAC Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type in 2019
Figure 47. APAC Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application in 2019
Figure 48. China Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 49. China Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 51. Japan Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 53. Korea Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 55. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 56. India Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 57. India Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 59. Australia Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Countries in 2019
Figure 61. Europe Xerostomia (Dry Mouth) Therapeutics Value Market Share by Countries in 2019
Figure 62. Europe Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type in 2019
Figure 63. Europe Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application in 2019
Figure 64. Germany Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 65. Germany Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 66. France Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 67. France Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 68. UK Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 69. UK Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 71. Italy Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 73. Russia Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption Market Share by Application in 2019
Figure 78. Egypt Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 79. Egypt Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 81. South Africa Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 83. Israel Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 85. Turkey Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Xerostomia (Dry Mouth) Therapeutics Consumption Growth 2015-2020 (K MT)
Figure 87. GCC Countries Xerostomia (Dry Mouth) Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 88. Global Xerostomia (Dry Mouth) Therapeutics Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 89. Global Xerostomia (Dry Mouth) Therapeutics Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 91. Americas Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 92. APAC Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 93. APAC Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 94. Europe Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 95. Europe Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 97. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 98. United States Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 99. United States Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 100. Canada Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 101. Canada Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 102. Mexico Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 103. Mexico Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 104. Brazil Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 105. Brazil Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 106. China Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 107. China Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 108. Japan Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 109. Japan Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 110. Korea Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 111. Korea Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 113. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 114. India Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 115. India Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 116. Australia Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 117. Australia Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 118. Germany Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 119. Germany Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 120. France Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 121. France Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 122. UK Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 123. UK Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 124. Italy Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 125. Italy Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 126. Russia Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 127. Russia Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 128. Spain Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 129. Spain Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 130. Egypt Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 131. Egypt Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 132. South Africa Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 133. South Africa Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 134. Israel Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 135. Israel Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 136. Turkey Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 137. Turkey Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Xerostomia (Dry Mouth) Therapeutics Consumption 2021-2025 (K MT)
Figure 139. GCC Countries Xerostomia (Dry Mouth) Therapeutics Value 2021-2025 ($ Millions)
Figure 140. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 141. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 142. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 143. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 144. Pendopharm Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 145. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 146. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 147. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 148. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 149. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Figure 150. OraCoat Xerostomia (Dry Mouth) Therapeutics Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets